Intrinsic Value of S&P & Nasdaq Contact Us

Ocugen, Inc. OCGN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+177.8%

Stock Statistics — OCGN

Ocugen, Inc. (OCGN) has a market capitalization of $590.21M and trades at $1.80. The 52-week range is 0.57-2.725.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.8, Earnings Per Share (EPS) of $-0.23, annual revenue of $4.41M.

The stock has a beta of 2.81, operates in the Healthcare sector.

Trading Data
Current Price$1.80
52-Week Range0.57-2.725
Volume4.5M
Avg Volume (30D)7.93M
Market Cap$590.21M
Beta (1Y)2.81
Company
IPO Date2014-12-03
Employees95
CEOShankar Musunuri
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS67577C1053
CUSIP67577C105
Income (Latest Year)
Revenue$4.41M
Gross Profit$2.02M
EBITDA$-60.53M
Operating Income$-62.92M
Net Income$-67.85M
EPS$-0.23
EPS Diluted$-0.23
Shares Outstanding$300.17M
Balance Sheet (Latest Year)
Total Assets$43.52M
Current Assets$24.34M
Cash & ST Investments$18.57M
Total Liabilities$56.46M
Total Debt$33.14M
Net Debt$14.57M
Total Equity$-12.17M
Debt / Equity-2.72
Valuation Ratios
P/E Ratio-7.8
P/S Ratio133.74
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message